Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Aker ASA: Invitation to presentation of fourth-quarter 2018 results

Aker ASA will publish its fourth-quarter and preliminary annual results for 2018 on the Oslo Stock Exchange on Thursday 14 February 2019.The results presentation will be held at Aker's headquarters at Fornebuporten, Oksenøyveien 10, at 09:00 CET on Thursday 14 February 2019. We invite investors, analysts and media to Aker's results presentation with President & CEO Øyvind Eriksen and CFO Frank O. Reite. Pre-registration is not required. Date: Thursday 14 February 2019Time: 09:00 a.m. CETFormat: Live webcastLanguage: English The webcast can be followed on Aker's website www.

TargetEveryone signs a new SpectrumOne customer and partner

TargetEveryone has today signed the Norwegian media agency Createurene as a new SpectrumOne customer. Createurene will also be a partner to TargetEveryone, with the ability to promote and sell SpectrumOne to larger clients. CEO, Torkel Johannessen says: After launching SpectrumOne, we experience good flow of incoming prospects. We are happy to see that we now also succeed in collaboration with partners that could both use and sell our solutions. I look forward to begin our partnership with Createurene.

CORRECTION: Notice to the Annual General Meeting of Shareholders of Fortum Corporation 2019

FORTUM CORPORATION STOCK EXCHANGE RELEASE 1 FEBRUARY 2019 AT 13.35 The Notice to Fortum’s Annual General Meeting 2019 contains an incorrect total amount of the dividend in the agenda point 8, third paragraph. Incorrect sentence: “Based on the number of registered shares as at 31 January 2019, the total amount of dividend would be EUR 977,203,749.50.”  Corrected sentence: “Based on the number of registered shares as at 31 January 2019, the total amount of dividend would be EUR 977,123,911.50.” Below the corrected release: The shareholders of Fortum Corporation are invited to

Invitation to YIT Corporation’s Annual General Meeting

YIT Corporation Stock Exchange Release February 1, 2019 at 1.05 p.m.The shareholders of YIT Corporation are invited to attend the Annual General Meeting to be held on Tuesday, March 12, 2019, starting at 10:00 a.m. (Finnish time GMT+2) in the Siipi section of the Messukeskus Expo & Convention Centre, located at the address Rautatieläisenkatu 3, FI-00520 Helsinki.  Check-in for those who have registered for the meeting, distribution of ballots and serving of coffee will start at the venue at 9:00 a.m.  A. Matters to be considered at the General Meeting  1. Opening of the meeting

Invitation to press- and telephone conference regarding Skanska’s Year-end report 2018 on February 8

Skanska’s Year-end report 2018 will be released on Friday, February 8 at 07:30 am CET.The report will be presented by Anders Danielsson, Skanska’s President and CEO, and Magnus Persson, CFO, at a press- and telephone conference at 10:00 am CET, at Skanska’s head office at Warfvinges väg 25 in Stockholm. The press conference will be webcasted live at www.skanska.com/investors, where it also will be posted shortly afterwards. To participate in the telephone conference, with the possibility to ask questions, please dial +46 8 505 564 74, or +44 203 364 5374, or +1 855 753 2230. After

YIT’s Financial Statements Bulletin 2018

YIT Corporation Stock Exchange Release February 1, 2019 at 1:00 p.m.Unless otherwise noted, the figures in brackets refer to the corresponding period in the previous year and are of the same unit. YIT reports in accordance with IFRS principles. YIT and Lemminkäinen merged on February 1, 2018. In this Financial Statements Bulletin 2018, comparison figures are pro forma figures. More information regarding the presentation of financial information is available at the end of the explanatory statement of the interim report. Both operating profit and cash flow were strong in the fourth quarter.

Invitation to press and analyst conference: Vattenfall to present 2018 full-year results on 7 February

Vattenfall’s 2018 year-end financial report will be published on Thursday 7 February at 08.00 CET on corporate.vattenfall.com . A press conference will start at 09.30 CET for media and analysts.Vattenfall’s President and CEO Magnus Hall and CFO Anna Borg will present the results at Vattenfall’s head office, Evenemangsgatan 13, Solna, Sweden. The press conference will be held in English. Please bring a press or ID card to attend.The press conference will be broadcasted in a live webcast on corporate.vattenfall.com .

Invitation to a conference call in connection with Arise’s Year-end report for 2018

Arise’s Year-end report for 2018 will be released on Friday 15 February, 2019 at around 08.00 CET.       At 11.00 on the same day a conference call will be held, hosted by Daniel Johansson, CEO and           Linus Hägg, CFO, who will present the report to the stock market and media. After the presentation those attending will be invited to ask questions. The dial in number for the conference call is: Sweden:                                        +46 8 566 427 07 UK:                                                +44 33 330 090 30 During the telephone conference a presentation

Company announcement no. 11, 2019 - Auctions of covered mortgage bonds in Nordea Kredit Realkreditaktieselskab.

The refinancing of Nordea Kredit ARMs with annual refinancing on 1 April 2019 will be conducted via auctions of covered mortgage bonds (SDRO). The covered mortgage bonds are rated Aaa and AAA by Moody´s and Standard & Poor´s, respectively. The auctions will be performed by Nordea Bank Abp and they will be held at the NASDAQ Copenhagen auction market on Tuesday, 5 February and Wednesday, 6 February 2019. The auctions will open daily at 9.00 a.m. and close either by 10.00 a.m. or 12.30 p.m. Investors will be notified of accepted bids as soon as possible after the closing of the auctions

Clinical trial of Inofer: last patient in

The last patient of twenty has now been included in the clinical study of the iron tablets Inofer, which Drugsson AB (subsidiary of Double Bond Pharmaceutical) has the rights to distribute in Sweden, Norway, Denmark and Finland. A clinical trial of Inofer was approved, as previously reported, by the Swedish Medical Products Agency and the National Ethical Committee June 20, 2018, and started on October 4 when the first patient received treatment with Inofer tablets. The study is being conducted at Skellefteå Hospital and is led by chief physician Kurt Boman, senior professor at Umeå

Lime Technologies AB's (publ) Nomination Committee for the 2019 Annual General Meeting

In accordance with the decision by Lime Technologies' Extraordinary General Meeting on October 16, 2018, the Chairman of the Board, Peter Larsson, has summoned the Nomination Committee. After consultation with the major shareholders of the company as per December 31, 2018, the committee consists of the following members:· Thomas Bill, representing Monterro 1 AB, · Jens Ismunden, representing Grenspecialisten AB, · Marianne Flink, representing Swedbank Robur Fonder AB, · Peter Larsson, Lime Technologies’ Chairman of the Board, is adjunct to the Nomination Committee. Erik Syrén,

EcoRub prefrains ordering new tranches

The board meeting on Thursday 2019 01 31 decided that EcoRub shall not order more Tranches from Bracknor and EHGOSF.Bracknor and  European High Growth Opportunities Securitization Fund (”EHGOSF”) has the right to two more tranches each at the value of 5 MSEK each. The agreement with EHGOSF say that 10 MSEK shall fall out within 12 months from October 2018 of which 5 MSEK  already has fallen out. The agreement with Bracknor reaches to October 2020. EcoRub´s board has per 2019 01 31 decided that the company by its own will shall not order more tranches. EHGOSF has converted 26 of  50 notes

Securitas AB to publish the full year report on Thursday, February 7, 2019

Securitas AB will publish the full year report for January-December 2019 on Thursday, February 7, at 8.00 a.m. (CET).8.00 a.m. (CET) Report releaseThe report will be sent as a press release from Cision (www.cision.se) and will automatically be published on www.securitas.com when released. 9.00 a.m. (CET) Presentation slides availableFor presentation slides, follow the link www.securitas.com/presentations 9.30 a.m. (CET) Telephone conference and audio castAnalysts and media are invited to participate in a telephone conference at 9.30 a.m. (CET) where Securitas President and CEO

Madden Marine charts 2019 business success

Madden Marine, one of Northern Ireland’s leading specialist ship refit companies has just completed work on the second of Stena Line’s five Irish Sea ferry refit projects at Belfast’s Harland and Wolff shipyard. The 10-week upgrade schedule will see five Stena Line vessels dry docked consecutively to facilitate refurbishment and maintenance works as part of a £5m investment programme. Stena Superfast X is currently in dry dock with Belfast-Cairnryan vessels Stena Superfast VII and VII due in Feb and March. Stephen Bryden, Stena Line Onboard Services Manager (Irish Sea North) said: “To

Exel Composites Plc to close its production facility in Germany

EXEL COMPOSITES PLC      STOCK EXCHANGE RELEASE    1 FEBRUARY 2019 at 11:00 EETExel Composites’ subsidiary Exel GmbH has agreed with the local works council, Betriebsrat, to close production in the Voerde manufacturing facility in Germany by 30 April 2019. The Voerde facility is Exel Composites’ smallest unit where composite profiles mainly to the telecommunications industry have been produced. As volumes have declined due to the continued challenging market situation of the telecommunications industry, the utilization level of the Voerde facility has been low. During February - April,

Calliditas Therapeutics to host conference call to provide Business Update and 2018 full-year report

On February 7, 2019, at 07:00am CET, Calliditas Therapeutics (“Calliditas”) will publish its business update for the full-year 2018. The company will also host a telephone conference, which will include a presentation of the results, on the same day at 3:00pm CET. The event will be hosted by the company’s CEO and President, Renée Aguiar-Lucander, and CFO Fredrik Johansson. The presentation will be held in English. The presentation will be live on the company’s website during the call under Financial Reports and Presentations and will also be made available online after the call. To

NOTICE TO GLASTON CORPORATION'S EXTRAORDINARY GENERAL MEETING

GLASTON CORPORATION STOCK EXCHANGE RELEASE                  1 FEBRUARY 2019 AT 10:50Notice is given to the shareholders of Glaston Corporation to the Extraordinary General Meeting to be held on Tuesday 26 February 2019 at 9.00 at Kansallissali at the address of Aleksanterinkatu 44, Helsinki, Finland. The reception of persons who have registered for the meeting and the distribution of voting ballots will commence at 8.30.  A. Matters on the agenda of the Extraordinary General Meeting  At the General Meeting, the following matters will be considered:  1. Opening of the meeting  2.

Glaston to carry out a reverse share split

GLASTON CORPORATION     STOCK EXCHANGE RELEASE                          1 FEBRUARY 2019 AT 10.45 AMAs Glaston Corporation (“Glaston” or “Company”) informed in its interim report 1 January 2018 – 30 September 2018 published on 31 October 2018, the Company has planned to reduce the number of all shares in the Company through a reverse share split procedure so that each five (5) shares shall be merged to one (1) share. The Board of Directors of Glaston proposes the reverse share split to the Extraordinary General Meeting to be held on 26 February 2019. The proposal by the Company’s Board of

Promore Pharma modifies its Phase III trial of PXL01 and expands the number of clinics in the study

STOCKHOLM, February 1, 2019 - Promore Pharma AB, a Swedish biopharmaceutical developer of therapeutic peptides, today announced that the company is making adjustments to the manufacturing chain of the investigational medicinal product for the company's clinical phase III study, PSHU03, with PXL01 for prevention of adhesions following tendon repair surgery. The adjustments mean that the provision of investigational medicinal product is delayed. To minimize the overall delay, the company intends to increase the number of clinics in order to enable faster recruitment of patients to the study.

The Nomination Committee’s proposal concerning Ratos’s Board of Directors and auditor ahead of the 2019 Annual General Meeting

Ratos’s Nomination Committee proposes that Eva Karlsson is elected as a new member of the Board of Directors at the 2019 Annual General Meeting. Annette Sadolin has informed the Nomination Committee that she intends to decline re-election at the Annual General Meeting. Ratos’s Nomination Committee also proposes that the audit firm Ernst & Young AB is elected as the company’s new auditor.Ratos’s Nomination Committee proposes that the 2019 Annual General Meeting elects six ordinary members of the Board of Directors, with no deputy directors. The Nomination Committee proposes the re-

Nixu’s Financial Statements Release 2018 to be published on February 28, 2019 at 8:30 AM EET

Nixu CorporationPress release, February 1, 2019 at 10:00 AM EETCybersecurity company Nixu will publish its Financial Statements Release 2018 on Thursday, February 28, 2019, at 8:30 AM EET and can be found at www.nixu.com/investors. News conference on Feb 28 at 9:30 AM EET Nixu CEO Petri Kairinen will present the financial results for 2018 and expectations for 2019 based on financials, strategy execution and cybersecurity market evolution at a news conference for analysts, investors and media on the same day, at 9:30 AM EET at Pörssitalo (Lehteri) at Fabianinkatu 14, Helsinki,

New CEO at United Spaces has profitability in focus

Yvonne Sörensen Björud is known for her superb financial results – for turning losses into profits, at such major brands as Svenskt Tenn and Berns Hotel. She will now step in as the new CEO for United Spaces.Yvonne Sörensen Björud is known for her superb financial results, for turning losses into profits, at such major brands as Svenskt Tenn and Berns Hotel. She will now step in as the new CEO for United Spaces. Yvonne Sörensen Björud arrives with impressive experience in management positions at successful companies within the decorating and hospitality industries, as well as a wide-

SMART WIRES WINS INNOVATION IN TECHNOLOGY AWARD FROM IRISH WIND ENERGY ASSOCIATION

A revolutionary power flow control system which can significantly increase the amount of renewable energy that the electricity grids can accommodate, has won the Irish Wind Energy Association’s (IWEA) Innovation in Technology award.SmartValve[TM], which was developed by pioneering power technology company, Smart Wires, helps electric utilities integrate renewables more efficiently and at a lower cost to consumers by controlling where power flows on the network. SmartValves enable operators to control the characteristics of power lines so they can push power off  overloaded lines or

Isofol Reports All Employees Participate in Newly Created Share Warrant Program

GOTHENBURG, Sweden, February 1, 2019 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced that all senior executives and employees participated in Isofol’s share warrant program “2018” (series 2018/2022 and series 2018/2023). A total of 1,260,139 warrants with the right to subscribe for new shares in Isofol were acquired. Management and employees have invested up to 207,000 Swedish Crowns (SEK) per person in the program.The warrants were acquired at a market price according to a calculation undertaken by Grant Thornton Sweden AB. At the end of each program, each

There are no items matching the current filter
There are no more items matching the current filter
Back to top